GlassScriptPhysician profile
Patrick Charles Hancock
NPI 1871945956
$9,993.02
in general payments reported to CMS, 2019-2025
13 companies · $2,080 in 2025
The $2,080 reported for 2025 was more than what 85% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.78 · 2021: $22.77 · 2022: $335 · 2023: $3,577 · 2024: $3,963 · 2025: $2,080.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,514 · Travel and Lodging: $4,106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,513.95 |
| Travel and Lodging | $4,106.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $5,470.51 | 2023-2025 | |
| Musculoskeletal Transplant Foundation INC. | $1,750.19 | 2022-2025 | |
| Integra Lifesciences Corporation | $810.39 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Mentor Worldwide LLC | $586.75 | 2024-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander |
| Acera Surgical, INC. | $319.61 | 2023 | Restrata Wound Matrix |
| Allergan, INC. | $275.64 | 2022 | |
| Stryker Corporation | $195.09 | 2024 | Vsp System, Vsp Cranial, Na |
| Kerecis Limited | $171.71 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Sanara Medtech INC. | $163.26 | 2024 | Celleraterx |
| Motiva USA, LLC | $141.15 | 2025 | |
| Lifenet Health | $71.17 | 2025 | Theragenesis Wound Matrix |
| Medtronic, INC. | $22.77 | 2021 | |
| Getinge USA Sales, LLC | $14.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Hancock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.